Title

A phase I trial of intraperitoneal (IP) mesothelin (MSLN)-targeted CAR T-cell therapy in patients with MSLN-positive esophagogastric cancer (EGC) with peritoneal carcinomatosis.

Authors

Choo, Joan; Saini, Jasmeen; Gonzalez - Aguirre, Adrian; Dahi, Parastoo; Hieronymi, Sophie; Fernstedt, Stacy; Tan, Kay See; Adusumilli, Prasad S.; Ku, Geoffrey Yuyat

Publication

Journal of Clinical Oncology, 2025, Vol 43, pTPS513

ISSN

0732-183X

Publication type

Academic Journal

DOI

10.1200/JCO.2025.43.4_suppl.TPS513